## **Core Concept**
Motion sickness, also known as travel sickness, is a condition that occurs when the body receives conflicting signals from the sensory systems, including the inner ear, eyes, and sensory nerves. The management of motion sickness involves pharmacological and non-pharmacological interventions.

## **Why the Correct Answer is Right**
The correct answer, Dimenhydrinate, is an antihistamine with significant anticholinergic properties. It is effective in preventing and treating motion sickness by blocking the histaminic receptors in the **vestibular system** and the **chemoreceptor trigger zone** in the brain. This action helps to reduce the conflicting signals that cause motion sickness.

## **Why Each Wrong Option is Incorrect**
* **Option A:** Ondansetron is a serotonin 5-HT3 receptor antagonist primarily used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. It is not the first choice for motion sickness.
* **Option B:** Metoclopramide is a dopamine antagonist with prokinetic and antiemetic properties. It is mainly used to treat nausea and vomiting caused by various conditions, including gastroparesis, but it is not typically used for motion sickness.
* **Option C:** This option is not provided, but based on the correct answer being Dimenhydrinate, any other option not listed would be incorrect for similar reasons.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that for motion sickness, **Dimenhydrinate** and **Scopolamine patches** are commonly used. Dimenhydrinate is usually taken 30 minutes to 1 hour before travel. A classic clinical pearl is that **Scopolamine patches** are particularly useful for long-duration travel and are applied behind the ear at least 4 hours before travel.

## **Correct Answer:** D. Dimenhydrinate.